{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T19:20:49Z","timestamp":1774380049620,"version":"3.50.1"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Aesth Plast Surg"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s00266-025-05411-9","type":"journal-article","created":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T20:24:18Z","timestamp":1762806258000},"page":"1329-1339","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Potential Role of Botulinum Neurotoxin Type A as a Supportive Intervention for Depressive Symptoms: A Systematic Review"],"prefix":"10.1007","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6063-0544","authenticated-orcid":false,"given":"Gerardo","family":"Altamura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleonora","family":"Marziali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valeria","family":"Puleo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriella","family":"Cassotta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annarita","family":"Panebianco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anadela Serra","family":"Visconti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,10]]},"reference":[{"key":"5411_CR1","unstructured":"World Health Organization. Depression. 2022. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/depression."},{"key":"5411_CR2","unstructured":"Institute of Health Metrics and Evaluation. Global Health Data Exchange (GHDx). https:\/\/vizhub.healthdata.org\/gbd-results\/. Accessed 4 Mar 2023."},{"issue":"Suppl 7","key":"5411_CR3","first-page":"1","volume":"60","author":"JR Davidson","year":"1999","unstructured":"Davidson JR, Meltzer-Brody SE. The underrecognition and undertreatment of depression: what is the breadth and depth of the problem? J Clin Psychiatry. 1999;60(Suppl 7):1\u20134.","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"5411_CR4","doi-asserted-by":"publisher","first-page":"309","DOI":"10.4103\/idoj.idoj_264_22","volume":"14","author":"G Arora","year":"2023","unstructured":"Arora G, Arora S. Medical aesthetics - current trends and a review of its applications. Indian Dermatol Online J. 2023;14(3):309\u201319.","journal-title":"Indian Dermatol Online J"},{"issue":"4","key":"5411_CR5","doi-asserted-by":"publisher","DOI":"10.1097\/GOX.0000000000003578","volume":"9","author":"DJ McKeown","year":"2021","unstructured":"McKeown DJ. Impact of minimally invasive aesthetic procedures on the psychological and social dimensions of health. Plast Reconstr Surg Glob Open. 2021;9(4):e3578.","journal-title":"Plast Reconstr Surg Glob Open"},{"key":"5411_CR6","unstructured":"Grand View Research. Aesthetic medicine market size, share & trends analysis report by procedure type (invasive procedures, non-invasive procedures), by region (North America, Asia Pacific, Europe), and segment forecasts, 2024 - 2030. Report ID: 978-1-680."},{"key":"5411_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/toxins14060383","author":"MA Wollmer","year":"2022","unstructured":"Wollmer MA, Magid M, Kruger THC, Finzi E. Treatment of depression with botulinum toxin. Toxins (Basel). 2022. https:\/\/doi.org\/10.3390\/toxins14060383.","journal-title":"Toxins (Basel)"},{"key":"5411_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/toxins16040191","author":"I Demchenko","year":"2024","unstructured":"Demchenko I, Swiderski A, Liu H, Jung H, Lou W, Bhat V. Botulinum toxin injections for psychiatric disorders: a systematic review of the clinical trial landscape. Toxins (Basel). 2024. https:\/\/doi.org\/10.3390\/toxins16040191.","journal-title":"Toxins (Basel)"},{"issue":"1","key":"5411_CR9","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/YIC.0000000000000290","volume":"35","author":"MF Brin","year":"2020","unstructured":"Brin MF, Durgam S, Lum A, James L, Liu J, Thase ME, et al. OnabotulinumtoxinA for the treatment of major depressive disorder: a phase 2 randomized, double-blind, placebo-controlled trial in adult females. Int Clin Psychopharmacol. 2020;35(1):19\u201328.","journal-title":"Int Clin Psychopharmacol"},{"issue":"6","key":"5411_CR10","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1055\/s-0035-1559621","volume":"48","author":"M Magid","year":"2015","unstructured":"Magid M, Finzi E, Kruger THC, Robertson HT, Keeling BH, Jung S, et al. Treating depression with botulinum toxin: a pooled analysis of randomized controlled trials. Pharmacopsychiatry. 2015;48(6):205\u201310.","journal-title":"Pharmacopsychiatry"},{"key":"5411_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2020.603087","author":"H Qian","year":"2020","unstructured":"Qian H, Shao F, Lenahan C, Shao A, Li Y. Efficacy and safety of botulinum toxin vs. placebo in depression: a systematic review and meta-analysis of randomized controlled trials. Front Psychiatry. 2020. https:\/\/doi.org\/10.3389\/fpsyt.2020.603087.","journal-title":"Front Psychiatry"},{"issue":"1","key":"5411_CR12","doi-asserted-by":"publisher","first-page":"211e","DOI":"10.1097\/PRS.0000000000009240","volume":"150","author":"JS Crowley","year":"2022","unstructured":"Crowley JS, Silverstein ML, Reghunathan M, Gosman AA. Glabellar botulinum toxin injection improves depression scores: a systematic review and meta-analysis. Plast Reconstr Surg. 2022;150(1):211e-e220.","journal-title":"Plast Reconstr Surg"},{"issue":"1","key":"5411_CR13","doi-asserted-by":"publisher","first-page":"14720","DOI":"10.1038\/s41598-018-33119-1","volume":"8","author":"MB Lewis","year":"2018","unstructured":"Lewis MB. The interactions between botulinum-toxin-based facial treatments and embodied emotions. Sci Rep. 2018;8(1):14720.","journal-title":"Sci Rep"},{"issue":"6","key":"5411_CR14","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1037\/bul0000194","volume":"145","author":"NA Coles","year":"2019","unstructured":"Coles NA, Larsen JT, Lench HC. A meta-analysis of the facial feedback literature: effects of facial feedback on emotional experience are small and variable. Psychol Bull. 2019;145(6):610\u201351.","journal-title":"Psychol Bull"},{"issue":"1","key":"5411_CR15","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s10919-017-0264-1","volume":"42","author":"S S\u00f6derkvist","year":"2018","unstructured":"S\u00f6derkvist S, Ohl\u00e9n K, Dimberg U. How the experience of emotion is modulated by facial feedback. J Nonverb Behav. 2018;42(1):129\u201351.","journal-title":"J Nonverb Behav"},{"issue":"3","key":"5411_CR16","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1037\/a0018690","volume":"10","author":"JI Davis","year":"2010","unstructured":"Davis JI, Senghas A, Brandt F, Ochsner KN. The effects of BOTOX injections on emotional experience. Emotion. 2010;10(3):433\u201340.","journal-title":"Emotion"},{"issue":"8","key":"5411_CR17","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1212\/WNL.53.8.1850","volume":"53","author":"FJ Erbguth","year":"1999","unstructured":"Erbguth FJ, Naumann M. Historical aspects of botulinum toxin: Justinus Kerner (1786\u20131862) and the \u201csausage poison.\u201d Neurology. 1999;53(8):1850\u20133.","journal-title":"Neurology"},{"issue":"1","key":"5411_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2958.1994.tb00396.x","volume":"13","author":"C Montecucco","year":"1994","unstructured":"Montecucco C, Schiavo G. Mechanism of action of tetanus and botulinum neurotoxins. Mol Microbiol. 1994;13(1):1\u20138.","journal-title":"Mol Microbiol"},{"issue":"5","key":"5411_CR19","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1007\/s00018-005-5505-5","volume":"63","author":"JA Chaddock","year":"2006","unstructured":"Chaddock JA, Marks PMH. Clostridial neurotoxins: structure-function led design of new therapeutics. Cell Mol Life Sci. 2006;63(5):540\u201351.","journal-title":"Cell Mol Life Sci"},{"issue":"29","key":"5411_CR20","doi-asserted-by":"publisher","first-page":"30865","DOI":"10.1074\/jbc.M403945200","volume":"279","author":"A Rummel","year":"2004","unstructured":"Rummel A, Karnath T, Henke T, Bigalke H, Binz T. Synaptotagmins I and II act as nerve cell receptors for botulinum neurotoxin G. J Biol Chem. 2004;279(29):30865\u201370.","journal-title":"J Biol Chem"},{"issue":"1","key":"5411_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-17509-0","volume":"12","author":"THC Kruger","year":"2022","unstructured":"Kruger THC, Schulze J, Bechinie A, Neumann I, Jung S, Sperling C, et al. Neuronal effects of glabellar botulinum toxin injections using a valenced inhibition task in borderline personality disorder. Sci Rep. 2022;12(1):14197.","journal-title":"Sci Rep"},{"issue":"8","key":"5411_CR22","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1177\/0269881121991827","volume":"35","author":"D Arnone","year":"2021","unstructured":"Arnone D, Galadari H, Rodgers CJ, \u00d6stlundh L, Aziz KA, Stip E, et al. Efficacy of onabotulinumtoxinA in the treatment of unipolar major depression: systematic review, meta-analysis and meta-regression analyses of double-blind randomised controlled trials. J Psychopharmacol. 2021;35(8):910\u20138.","journal-title":"J Psychopharmacol"},{"issue":"6","key":"5411_CR23","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1111\/bph.15753","volume":"179","author":"\u00c9 Borb\u00e9ly","year":"2022","unstructured":"Borb\u00e9ly \u00c9, Simon M, Fuchs E, Wiborg O, Cz\u00e9h B, Helyes Z. Novel drug developmental strategies for treatment-resistant depression. Br J Pharmacol. 2022;179(6):1146\u201386.","journal-title":"Br J Pharmacol"},{"key":"5411_CR24","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.jad.2022.08.097","volume":"318","author":"Y Li","year":"2022","unstructured":"Li Y, Zhu T, Shen T, Wu W, Cao J, Sun J, et al. Botulinum toxin A (BoNT\/A) for the treatment of depression: a randomized, double-blind, placebo, controlled trial in China. J Affect Disord. 2022;318:48\u201353.","journal-title":"J Affect Disord"},{"issue":"8","key":"5411_CR25","doi-asserted-by":"publisher","first-page":"837","DOI":"10.4088\/JCP.13m08845","volume":"75","author":"M Magid","year":"2014","unstructured":"Magid M, Reichenberg JS, Poth PE, Robertson HT, LaViolette AK, Kruger THC, et al. Treatment of major depressive disorder using botulinum toxin A: a 24-week randomized, double-blind, placebo-controlled study. J Clin Psychiatry. 2014;75(8):837\u201344.","journal-title":"J Clin Psychiatry"},{"issue":"5","key":"5411_CR26","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.jpsychires.2012.01.027","volume":"46","author":"MA Wollmer","year":"2012","unstructured":"Wollmer MA, de Boer C, Kalak N, Beck J, G\u00f6tz T, Schmidt T, et al. Facing depression with botulinum toxin: a randomized controlled trial. J Psychiatr Res. 2012;46(5):574\u201381. https:\/\/doi.org\/10.1016\/j.jpsychires.2012.01.027.","journal-title":"J Psychiatr Res"},{"key":"5411_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/toxins13100694","author":"S Kongsaengdao","year":"2021","unstructured":"Kongsaengdao S, Arayawithchanont A, Samintharapanya K, Rojanapitayakorn P, Maneeton B, Maneeton N. Low-dose neubotulinum toxin A versus low-dose abobotulinum toxin A injection for the treatment of cervical dystonia: a multicenter, 48-week, prospective, double-blinded, randomized crossover design study. Toxins (Basel). 2021. https:\/\/doi.org\/10.3390\/toxins13100694.","journal-title":"Toxins (Basel)"},{"issue":"1","key":"5411_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jpsychires.2013.11.006","volume":"52","author":"E Finzi","year":"2014","unstructured":"Finzi E, Rosenthal NE. Treatment of depression with onabotulinumtoxinA: a randomized, double-blind, placebo controlled trial. J Psychiatr Res. 2014;52(1):1\u20136. https:\/\/doi.org\/10.1016\/j.jpsychires.2013.11.006.","journal-title":"J Psychiatr Res"},{"issue":"1","key":"5411_CR29","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1097\/PRA.0000000000000277","volume":"24","author":"S Chugh","year":"2018","unstructured":"Chugh S, Chhabria A, Jung S, Kruger THC, Wollmer MA. Botulinum toxin as a treatment for depression in a real-world setting. J Psychiatr Pract. 2018;24(1):15\u201320.","journal-title":"J Psychiatr Pract"},{"issue":"8","key":"5411_CR30","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.parkreldis.2007.03.006","volume":"13","author":"S Ochudlo","year":"2007","unstructured":"Ochudlo S, Bryniarski P, Opala G. Botulinum toxin improves the quality of life and reduces the intensification of depressive symptoms in patients with blepharospasm. Parkinsonism Relat Disord. 2007;13(8):505\u20138.","journal-title":"Parkinsonism Relat Disord"},{"key":"5411_CR31","doi-asserted-by":"crossref","unstructured":"Lehnert F, Neumann I, Kr\u00fcger THC, Wollmer MA. Botulinum toxin therapy for psychiatric disorders in clinical practice: a retrospective case study. Toxins (Basel). 2023;15 (6). Available from: https:\/\/www.mdpi.com\/2072-6651\/15\/6\/385","DOI":"10.3390\/toxins15060385"},{"issue":"3","key":"5411_CR32","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1136\/jnnp-2018-319290","volume":"90","author":"AM Blumenfeld","year":"2019","unstructured":"Blumenfeld AM, Tepper SJ, Robbins LD, Manack Adams A, Buse DC, Orejudos A, et al. Effects of onabotulinumtoxin A treatment for chronic migraine on common comorbidities including depression and anxiety. J Neurol Neurosurg Psychiatry [Internet]. 2019;90(3):353\u201360.","journal-title":"J Neurol Neurosurg Psychiatry [Internet]."},{"key":"5411_CR33","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.2147\/NDT.S152252","volume":"14","author":"S Kongsaengdao","year":"2018","unstructured":"Kongsaengdao S, Maneeton N, Maneeton B. Long-term quality of life in cervical dystonia after treatment with abobotulinum toxin A: a 2-year prospective study. Neuropsychiatr Dis Treat. 2018;14:1119\u201324.","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"7","key":"5411_CR34","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1007\/s10072-016-2568-z","volume":"37","author":"M Russo","year":"2016","unstructured":"Russo M, Manzoni GC, Taga A, Genovese A, Veronesi L, Pasquarella C, et al. The use of onabotulinum toxin A (Botox\u00ae) in the treatment of chronic migraine at the Parma Headache Centre: a prospective observational study. Neurol Sci. 2016;37(7):1127\u201331.","journal-title":"Neurol Sci"},{"key":"5411_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/toxins15060385","author":"F Lehnert","year":"2023","unstructured":"Lehnert F, Neumann I, Kr\u00fcger THC, Wollmer MA. Botulinum toxin therapy for psychiatric disorders in clinical practice: a retrospective case study. Toxins (Basel). 2023. https:\/\/doi.org\/10.3390\/toxins15060385.","journal-title":"Toxins (Basel)"},{"issue":"3","key":"5411_CR36","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1136\/jnnp-2018-319290","volume":"90","author":"AM Blumenfeld","year":"2019","unstructured":"Blumenfeld AM, Tepper SJ, Robbins LD, Manack Adams A, Buse DC, Orejudos A, et al. Effects of onabotulinumtoxinA treatment for chronic migraine on common comorbidities including depression and anxiety. J Neurol Neurosurg Psychiatry. 2019;90(3):353\u201360.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"5411_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/toxins13100694","author":"S Kongsaengdao","year":"2021","unstructured":"Kongsaengdao S, Arayawithchanont A, Samintharapanya K, Rojanapitayakorn P, Maneeton B, Maneeton N. Low-dose neubotulinum toxin A versus low-dose abobotulinum toxin A injection for the treatment of cervical dystonia: a multicenter, 48-week, prospective, double-blinded, randomized crossover design study. Toxins (Basel). 2021. https:\/\/doi.org\/10.3390\/toxins13100694.","journal-title":"Toxins (Basel)"},{"issue":"1","key":"5411_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jpsychires.2013.11.006","volume":"52","author":"E Finzi","year":"2014","unstructured":"Finzi E, Rosenthal NE. Treatment of depression with onabotulinumtoxinA: a randomized, double-blind, placebo controlled trial. J Psychiatr Res. 2014;52(1):1\u20136.","journal-title":"J Psychiatr Res"},{"issue":"2","key":"5411_CR39","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1097\/PRA.0000000000000136","volume":"22","author":"AK Parsaik","year":"2016","unstructured":"Parsaik AK, Mascarenhas SS, Hashmi A, Prokop LJ, John V, Okusaga O, et al. Role of botulinum toxin in depression. J Psychiatr Pract. 2016;22(2):99\u2013110.","journal-title":"J Psychiatr Pract"},{"key":"5411_CR40","doi-asserted-by":"crossref","unstructured":"Finzi E. Botulinum Toxin treatment for depression: a new paradigm for psychiatry. Toxins (Basel). 2023;15(5).","DOI":"10.3390\/toxins15050336"},{"key":"5411_CR41","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.pnpbp.2017.04.008","volume":"77","author":"Q Wang","year":"2017","unstructured":"Wang Q, Timberlake MA, Prall K, Dwivedi Y. The recent progress in animal models of depression. Prog Neuro-Psychopharmacol Biol Psychiatry. 2017;77:99\u2013109.","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"5411_CR42","doi-asserted-by":"crossref","unstructured":"Ni L, Chen H, Xu X, Sun D, Cai H, Wang L, et al. Neurocircuitry underlying the antidepressant effect of retrograde facial botulinum toxin in mice. Cell Biosci. 2023;13(1).","DOI":"10.1186\/s13578-023-00964-1"},{"issue":"617","key":"5411_CR43","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.neulet.2016.02.020","volume":"23","author":"S Ibragi\u0107","year":"2016","unstructured":"Ibragi\u0107 S, Matak I, Dra\u010di\u0107 A, Smajlovi\u0107 A, Muminovi\u0107 M, Proft F, et al. Effects of botulinum toxin type A facial injection on monoamines and their metabolites in sensory, limbic and motor brain regions in rats. Neurosci Lett. 2016;23(617):213\u20137.","journal-title":"Neurosci Lett"},{"key":"5411_CR44","doi-asserted-by":"crossref","unstructured":"Antipova V, Holzmann C, Hawlitschka A, Witt M, Wree A. Antidepressant\u2010like properties of intrastriatal botulinum neurotoxin\u2010a injection in a unilateral 6\u2010ohda rat model of parkinson\u2019s disease. Toxins (Basel). 2021;13(7).","DOI":"10.3390\/toxins13070505"},{"key":"5411_CR45","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1002\/wps.20229","volume":"14","author":"PJ Cowen","year":"2015","unstructured":"Cowen PJ, Browning M. What has serotonin to do with depression? World Psychiatry. 2015;14:158\u201360.","journal-title":"World Psychiatry"},{"issue":"3","key":"5411_CR46","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1177\/02698811231161813","volume":"37","author":"S Jauhar","year":"2023","unstructured":"Jauhar S, Cowen PJ, Browning M. Fifty years on: Serotonin and depression. J Psychopharmacol. 2023;37(3):237\u201341.","journal-title":"J Psychopharmacol"},{"issue":"504","key":"5411_CR47","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1192\/bjp.113.504.1237","volume":"113","author":"A Coppen","year":"1967","unstructured":"Coppen A. The biochemistry of affective disorders. Brit J Psychiatry [Internet]. 1967;113(504):1237\u201364.","journal-title":"Brit J Psychiatry [Internet]."},{"key":"5411_CR48","first-page":"143","volume-title":"Effects of serotonin in the hippocampus: How SSRIs and multimodal antidepressants might regulate pyramidal cell function CNS Spectrums","author":"E Dale","year":"2016","unstructured":"Dale E, Pehrson AL, Jeyarajah T, Li Y, Leiser SC, Smagin G, et al. Effects of serotonin in the hippocampus: How SSRIs and multimodal antidepressants might regulate pyramidal cell function CNS Spectrums, vol. 21. Cambridge: Cambridge University Press; 2016. p. 143\u201361."},{"key":"5411_CR49","first-page":"28","volume":"1","author":"KD Young","year":"2020","unstructured":"Young KD, Friedman ES, Collier A, Berman SR, Feldmiller J, Haggerty AE, et al. Response to SSRI intervention and amygdala activity during self-referential processing in major depressive disorder. Neuroimage Clin. 2020;1:28.","journal-title":"Neuroimage Clin."},{"issue":"6","key":"5411_CR50","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.jaad.2007.10.649","volume":"58","author":"M Alam","year":"2008","unstructured":"Alam M, Barrett KC, Hodapp RM, Arndt KA. Botulinum toxin and the facial feedback hypothesis: can looking better make you feel happier? J Am Acad Dermatol. 2008;58(6):1061\u201372.","journal-title":"J Am Acad Dermatol"},{"key":"5411_CR51","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/9724371","volume":"2017","author":"J Sheng","year":"2017","unstructured":"Sheng J, Liu S, Wang Y, Cui R, Zhang X. The link between depression and chronic pain: neural mechanisms in the brain. Neural Plast. 2017;2017:9724371.","journal-title":"Neural Plast"},{"issue":"6","key":"5411_CR52","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1097\/HRP.0000000000000198","volume":"26","author":"WW IsHak","year":"2018","unstructured":"IsHak WW, Wen RY, Naghdechi L, Vanle B, Dang J, Knosp M, et al. Pain and depression: a systematic review. Harv Rev Psychiatry. 2018;26(6):352\u201363.","journal-title":"Harv Rev Psychiatry"},{"issue":"S6","key":"5411_CR53","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.5694\/mja12.10589","volume":"199","author":"A Holmes","year":"2013","unstructured":"Holmes A, Christelis N, Arnold C. Depression and chronic pain. Med J Aust. 2013;199(S6):S17-20.","journal-title":"Med J Aust"},{"issue":"1","key":"5411_CR54","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1136\/jnnp.64.1.13","volume":"64","author":"W Poewe","year":"1998","unstructured":"Poewe W, Deuschl G, Nebe A, Feifel E, Wissel J, Benecke R, et al. What is the optimal dose of botulinum toxin A in the treatment of cervical dystonia? Results of a double blind, placebo controlled, dose ranging study using Dysport. J Neurol Neurosurg Psychiatry. 1998;64(1):13\u20137.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"5411_CR55","doi-asserted-by":"publisher","first-page":"189","DOI":"10.2310\/7010.2006.00041","volume":"21","author":"EM Goldstein","year":"2006","unstructured":"Goldstein EM. Safety of high-dose botulinum toxin type A therapy for the treatment of pediatric spasticity. J Child Neurol. 2006;21(3):189\u201392.","journal-title":"J Child Neurol"},{"issue":"1","key":"5411_CR56","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1097\/IOP.0000000000002169","volume":"39","author":"M Gostimir","year":"2023","unstructured":"Gostimir M, Liou V, Yoon MK. Safety of botulinum toxin A injections for facial rejuvenation: a meta-analysis of 9,669 patients. Ophthalmic Plast Reconstr Surg. 2023;39(1):13\u201325.","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"5","key":"5411_CR57","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1111\/dsu.12463","volume":"40","author":"M Cavallini","year":"2014","unstructured":"Cavallini M, Cirillo P, Fundar\u00f2 SP, Quartucci S, Sciuto C, Sito G, et al. Safety of botulinum toxin A in aesthetic treatments: a systematic review of clinical studies. Dermatol Surg. 2014;40(5):525\u201336.","journal-title":"Dermatol Surg"},{"issue":"7","key":"5411_CR58","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1185\/030079904125003962","volume":"20","author":"M Naumann","year":"2004","unstructured":"Naumann M, Jankovic J. Safety of botulinum toxin type A: a systematic review and meta-analysis. Curr Med Res Opin. 2004;20(7):981\u201390.","journal-title":"Curr Med Res Opin"},{"issue":"6","key":"5411_CR59","doi-asserted-by":"publisher","first-page":"853","DOI":"10.5114\/ada.2019.82795","volume":"37","author":"H Witmanowski","year":"2020","unstructured":"Witmanowski H, B\u0142ochowiak K. The whole truth about botulinum toxin - a review. Postepy Dermatol Alergol. 2020;37(6):853\u201361.","journal-title":"Postepy Dermatol Alergol"},{"key":"5411_CR60","doi-asserted-by":"publisher","first-page":"329","DOI":"10.2147\/CCID.S446891","volume":"17","author":"WG Philipp-Dormston","year":"2024","unstructured":"Philipp-Dormston WG, De Boulle K, Gronovich Y, Lowe N, Sayed K, Sykianakis D, et al. The patient journey in facial aesthetics: findings from a european consensus meeting on improving the quality of life for patients receiving botulinum toxin injections. Clin Cosmet Investig Dermatol. 2024;17:329\u201337.","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"suppl_1","key":"5411_CR61","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.1093\/asj\/sjx010","volume":"37","author":"JL Cohen","year":"2017","unstructured":"Cohen JL, Scuderi N. Safety and patient satisfaction of abobotulinumtoxina for aesthetic use: a systematic review. Aesthet Surg J. 2017;37(suppl_1):S32-44.","journal-title":"Aesthet Surg J"}],"container-title":["Aesthetic Plastic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00266-025-05411-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00266-025-05411-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00266-025-05411-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T17:02:45Z","timestamp":1773680565000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00266-025-05411-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,10]]},"references-count":61,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["5411"],"URL":"https:\/\/doi.org\/10.1007\/s00266-025-05411-9","relation":{},"ISSN":["0364-216X","1432-5241"],"issn-type":[{"value":"0364-216X","type":"print"},{"value":"1432-5241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,10]]},"assertion":[{"value":"8 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest related to this research, authorship, and\/or publication of this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights\/Ethical Approval"}},{"value":"For this type of study, informed consent is not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}]}}